Previous studies have revealed that plasma Aβ1–40 is increased in familial AD with mutations in the genes encoding presenilin or the amyloid precursor protein [45, 46], in patients with Down’s syndrome [47, 48], and in first-degree relatives of AD patients who are at increased risk of developing the disease [49]. The gene discussed is APP; the disease is Alzheimer disease.